KaloBios raises $70M in an IPO

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO) raised $70 million through the sale of 8.8 million shares at $8 in an IPO underwritten by Leerink; William Blair; and Needham. The price values KaloBios at $191.1 million. On Wednesday, the antibody company amended its IPO and said it would sell 8.3 million shares at $8-$9 after amending the offering earlier this month to sell 3.9 million shares at $12-$14. In October, KaloBios proposed to raise up to $60 million in an IPO after becoming a publicly reporting company via the Form 10 pathway. KaloBios was unchanged at $8 in its first day of trading on Thursday. ...